Skip to main content

Finance & Markets

Eli Lilly Is Acquiring Merdia Biosciences for Up to $2.88 Billion. Here's What That Means for Investors.

Hardly for the first time recently, the company is making a pricey acquisition.

fool.com ·2h ago

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Eli Lilly Is Acquiring Merdia Biosciences for Up to $2.88 Billion. Here's What That Means for Investors. nasdaq.com

Read the original at fool.com →

More in Finance & Markets

Sono Group signs non-binding LOI with Sports One; investors buy 19.9% stake

2h ago ·seekingalpha.com

Gold slides to two-week low as higher oil prices, hawkish Fed outlook keep yields high

2h ago ·seekingalpha.com

Scheffler Vs. Clark: Player Of The Year Race Comes Down To The Wire

Scottie Scheffler wins the Tour Championship, passes Tiger Woods in career earnings and enters the Player of the Year debate with Wyndham Clark after a dominant 2026 season.

2h ago ·forbes.com

KKR-backed OPI nail polish owner Wella Co files for US IPO

2h ago ·investing.com

Gorilla (GRRR) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo

2h ago ·nasdaq.com

Trump says Exxon is ’going in’ to Venezuela as US pushes oil deals

2h ago ·investing.com

More from Monday 31 August →